US gainers
US losers
Hong Kong gainers
Hong Kong losers
Oct 14Latest
Oct 13
Oct 12
Oct 9
‹ Previous day
Next day ›
Top US Stock Losers · Oct 13 · 30
Tue, Oct 13, 2026 · Close
Screen: share price of at least $5, market cap of roughly $2 billion or more, and a decline of more than 2.5% on the day; the 30 largest moves are shown. Turnover is estimated as volume × last price. Source: Yahoo Finance.
Cipher Digital
US CIFR
11.34
-12.77%
Change -1.66
Turnover (est.) $1.40B
Market cap $4.71B
52-wk high 30.14
52-wk low 10.68
Pershing Square
US PS
47.42
-12.53%
Change -6.80
Turnover (est.) $18.2M
Market cap $18.97B
52-wk high 60.40
52-wk low 22.01
Change -5.07
Turnover (est.) $50.1M
Market cap $2.01B
52-wk high 71.69
52-wk low 23.55
Summit Therapeutics
US SMMT
15.52
-9.40%
Change -1.61
Turnover (est.) $109.8M
Market cap $12.38B
52-wk high 29.23
52-wk low 12.07
ChronoScale
US CHRN
16.31
-8.78%
Change -1.57
Turnover (est.) $5.0M
Market cap $2.37B
52-wk high 30.00
52-wk low 3.50
AST SpaceMobile
US ASTS
47.06
-8.54%
Change -4.40
Turnover (est.) $1.07B
Market cap $18.32B
52-wk high 133.86
52-wk low 46.24
Immunome
US IMNM
17.58
-8.20%
Change -1.57
Turnover (est.) $36.0M
Market cap $2.07B
52-wk high 30.06
52-wk low 13.54
Tango Therapeutics
US TNGX
22.22
-8.07%
Change -1.95
Turnover (est.) $212.0M
Market cap $3.75B
52-wk high 34.39
52-wk low 6.69
BETA Technologies
US BETA
18.22
-8.07%
Change -1.60
Turnover (est.) $36.4M
Market cap $4.26B
52-wk high 39.50
52-wk low 13.43
Kodiak Sciences
US KOD
91.63
-7.69%
Change -7.63
Turnover (est.) $136.7M
Market cap $5.76B
52-wk high 104.00
52-wk low 10.94
Arcus Biosciences
US RCUS
22.47
-7.68%
Change -1.87
Turnover (est.) $24.8M
Market cap $2.86B
52-wk high 31.73
52-wk low 15.38
Mirum Pharmaceuticals
US MIRM
79.62
-7.48%
Change -6.44
Turnover (est.) $58.9M
Market cap $5.17B
52-wk high 130.00
52-wk low 63.23
Pulse Biosciences
US PLSE
48.54
-7.45%
Change -3.91
Turnover (est.) $21.7M
Market cap $3.46B
52-wk high 58.90
52-wk low 12.56
Parabilis Medicines
US PBLS
26.85
-7.25%
Change -2.10
Turnover (est.) $31.5M
Market cap $3.32B
52-wk high 42.49
52-wk low 24.51
GitLab
US GTLB
51.95
-7.25%
Change -4.06
Turnover (est.) $473.6M
Market cap $8.66B
52-wk high 57.89
52-wk low 18.73
BioNTech
US BNTX
89.01
-7.13%
Change -6.83
Turnover (est.) $168.6M
Market cap $22.36B
52-wk high 124.00
52-wk low 79.52
Change -2.51
Turnover (est.) $74.6M
Market cap $4.99B
52-wk high 57.25
52-wk low 32.40
Fervo Energy
US FRVONear 52-wk low
11.98
-6.92%
Change -0.89
Turnover (est.) $133.2M
Market cap $3.53B
52-wk high 42.65
52-wk low 11.89
Applied Materials
US AMAT
464.24
-6.69%
Change -33.29
Turnover (est.) $4.85B
Market cap $368.42B
52-wk high 739.67
52-wk low 203.40
SSR Mining
US SSRM
33.10
-6.60%
Change -2.34
Turnover (est.) $122.9M
Market cap $6.87B
52-wk high 39.44
52-wk low 18.19
Uranium Energy
US UECNear 52-wk low
8.25
-6.57%
Change -0.58
Turnover (est.) $120.8M
Market cap $4.09B
52-wk high 20.34
52-wk low 8.19
SentinelOne
US S
23.99
-6.51%
Change -1.67
Turnover (est.) $514.4M
Market cap $8.35B
52-wk high 26.50
52-wk low 11.81
Disc Medicine
US IRON
56.60
-6.42%
Change -3.88
Turnover (est.) $33.3M
Market cap $2.17B
52-wk high 99.50
52-wk low 40.00
Spyre Therapeutics
US SYRE
80.45
-6.34%
Change -5.45
Turnover (est.) $114.0M
Market cap $7.52B
52-wk high 110.17
52-wk low 18.71
Fabrinet
US FN
428.27
-6.16%
Change -28.13
Turnover (est.) $424.7M
Market cap $15.35B
52-wk high 748.89
52-wk low 366.49
Zai Lab
US ZLAB
23.10
-6.06%
Change -1.49
Turnover (est.) $17.9M
Market cap $2.59B
52-wk high 30.18
52-wk low 15.96
Viking Therapeutics
US VKTX
26.65
-5.96%
Change -1.69
Turnover (est.) $150.2M
Market cap $3.39B
52-wk high 43.15
52-wk low 25.77
Axsome Therapeutics
US AXSM
156.32
-5.83%
Change -9.68
Turnover (est.) $192.3M
Market cap $8.19B
52-wk high 260.19
52-wk low 120.12
MBX Biosciences
US MBX
49.00
-5.81%
Change -3.02
Turnover (est.) $36.9M
Market cap $2.36B
52-wk high 72.64
52-wk low 12.94
Johnson & Johnson
US JNJ
248.69
-5.70%
Change -15.05
Turnover (est.) $3.36B
Market cap $599.31B
52-wk high 281.07
52-wk low 184.66
The first standard report for a new stock is free. Valuation and “Why it fell” are paid features; the cost is shown before you submit. Public reports that already exist open directly.
This page organizes public market data. It is not a recommendation list or investment advice. Quotes may be delayed or contain errors; rely on the exchange and your broker for official data.